secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001493152-24-020292
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition postpones extraordinary general meeting to May 21; shareholders to vote on extension to Feb 2025
--------------------------------------------------------------------------------

- Meeting postponed from May 17 to May 21, 2024 at 9:00 a.m. ET.
- Shareholders will vote on extending business combination deadline from May 23, 2024 to February 17, 2025.
- Redemption deadline extended to May 17, 2024; shareholders can withdraw previously submitted requests.
- No changes to record date, location, or proposals to be voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224020292/0001493152-24-020292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224020292/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer